SHARMEH P/E Ratio
Current P/E Ratio
24.38
Moderate Valuation
High - Growth expectations or overvalued
SHARMEH P/E ratio. SHARMEH (SHARMEH) P/E ratio is 24.38 (Moderate), EPS (TTM) ₹3.78, current price ₹87.57 on BSE — High - Growth expectations or overvalued. Also explore SHARMEH share price history to track price trends across different timeframes.
Current Valuation Metrics
P/E Ratio
24.38
Current Price
₹87.57
EPS (TTM)
₹3.78
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
94.46
Sector Median
44.39
Sector Rank
#11 of 57
Sector Percentile
19.3%
SHARMEH P/E Ratio — Valuation Signal & Historical Context
SHARMEH P/E 24.38 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see SHARMEH share price chart.
- Trading at discount to sector average PE of 94.46
SHARMEH vs Healthcare Services Peers — P/E Ratio Comparison
SHARMEH P/E 24.38 vs Healthcare Services average 94.46, median 44.39 — range 6.79–1642.14.
Sector Average
94.46
Sector Median
44.39
Lowest P/E
6.79
Highest P/E
1642.14
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.79 | ₹131 | Low |
| Abate AS Industries | ABATEAS | 10.23 | ₹122 | Low |
| Deccan Health Care | DECCAN | 11.6 | ₹29 | Low |
| Nidan Labs & Healthcare | NIDAN | 11.94 | ₹17 | Low |
| One Global Service Provi… | ONEGLOBAL | 13.97 | ₹1,027 | Low |
| Shanmuga Hospital | SHANMUGA | 14.1 | ₹61 | Low |
| Indraprastha Medical Cor… | INDRAMEDCO | 16.52 | ₹3,061 | Moderate |
| Invicta Diagnostic | INVICTA | 17.24 | ₹85 | Moderate |
| Dhanvantri Jeevan Rekha | ZDHJERK | 18.19 | ₹9 | Moderate |
| Clinitech Laboratory | CTLLAB | 18.49 | ₹8 | Moderate |